Small-molecule SMAC mimetics as new cancer therapeutics

被引:169
作者
Bai, Longchuan
Smith, David C.
Wang, Shaomeng
机构
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Int Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA
关键词
SMAC mimetics; Apoptosis; Inhibitors; NF-KAPPA-B; X-LINKED INHIBITOR; TRAIL-INDUCED APOPTOSIS; MIXED LINEAGE KINASE; CELL-DEATH COMPLEX; C-RAF KINASE; STRUCTURAL BASIS; IAP PROTEINS; ANTAGONISTS INDUCE; PROMOTES APOPTOSIS;
D O I
10.1016/j.pharmthera.2014.05.007
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Apoptosis is a tightly regulated cellular process and faulty regulation of apoptosis is a hallmark of human cancers. Targeting key apoptosis regulators with the goal to restore apoptosis in tumor cells has been pursued as a new cancer therapeutic strategy. XIAP, cIAP1, and cIAP2, members of inhibitor of apoptosis (IAP) proteins, are critical regulators of cell death and survival and are attractive targets for new cancer therapy. The SMAC/DIABLO protein is an endogenous antagonist of XIAP, cIAP1, and cIAP2. In the last decade, intense research efforts have resulted in the design and development of several small-molecule SMAC mimetics now in clinical trials for cancer treatment. In this review, we will discuss the roles of XIAP, cIAP1, and cIAP2 in regulation of cell death and survival, and the design and development of small-molecule SMAC mimetics as novel cancer treatments. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:82 / 95
页数:14
相关论文
共 149 条
[1]   RIP1 is required for IAP inhibitor-mediated sensitization for TRAIL-induced apoptosis via a RIP1/FADD/caspase-8 cell death complex [J].
Abhari, B. A. ;
Cristofanon, S. ;
Kappler, R. ;
von Schweinitz, D. ;
Humphreys, R. ;
Fulda, S. .
ONCOGENE, 2013, 32 (27) :3263-3273
[2]   Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism [J].
Allensworth, Jennifer L. ;
Sauer, Scott J. ;
Lyerly, H. Kim ;
Morse, Michael A. ;
Devi, Gayathri R. .
BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) :359-371
[3]   Phase 1 study of the Smac mimetic TL32711 in adult subjects with advanced solid tumors and lymphoma to evaluate safety, pharmacokinetics, pharmacodynamics, and antitumor activity [J].
Amaravadi, Ravi K. ;
Schilder, Russell J. ;
Dy, Grace K. ;
Ma, Wen W. ;
Fetterly, Gerald J. ;
Weng, David E. ;
Graham, Martin A. ;
Burns, Jennifer M. ;
Chunduru, Srinivas K. ;
Condon, Stephen M. ;
McKinlay, Mark A. ;
Adjei, Alex A. .
CANCER RESEARCH, 2011, 71
[4]  
Amaravadi RK, 2013, J CLIN ONCOL, V31
[5]   Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma [J].
Annunziata, Christina M. ;
Davis, R. Eric ;
Demchenko, Yulia ;
Bellamy, William ;
Gabrea, Ana ;
Zhan, Fenghuang ;
Lenz, Georg ;
Hanamura, Ichiro ;
Wright, George ;
Xiao, Wenming ;
Dave, Sandeep ;
Hurt, Elaine M. ;
Tan, Bruce ;
Zhao, Hong ;
Stephens, Owen ;
Santra, Madhumita ;
Williams, David R. ;
Dang, Lenny ;
Barlogie, Bart ;
Shaughnessy, John D., Jr. ;
Kuehl, W. Michael ;
Staudt, Louis M. .
CANCER CELL, 2007, 12 (02) :115-130
[6]  
BAI L, 2014, ANN REV MED, V65
[7]   LRIG1 Modulates Cancer Cell Sensitivity to Smac Mimetics by Regulating TNFα Expression and Receptor Tyrosine Kinase Signaling [J].
Bai, Longchuan ;
McEachern, Donna ;
Yang, Chao-Yie ;
Lu, Jianfeng ;
Sun, Haiying ;
Wang, Shaomeng .
CANCER RESEARCH, 2012, 72 (05) :1229-1238
[8]   Rho GTPase Effector Functions in Tumor Cell Invasion and Metastasis [J].
Baranwal, Somesh ;
Alahari, Suresh K. .
CURRENT DRUG TARGETS, 2011, 12 (08) :1194-1201
[9]   RIP1 Protein-dependent Assembly of a Cytosolic Cell Death Complex Is Required for Inhibitor of Apoptosis (IAP) Inhibitor-mediated Sensitization to Lexatumumab-induced Apoptosis [J].
Basit, Farhan ;
Humphreys, Robin ;
Fulda, Simone .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (46) :38767-38777
[10]  
BENETATOS CA, 2014, MOL CANC THER